ADGRE2 and systemic inflammatory response syndrome: Consistent with our data, the increased expression of EMR2 on circulating granulocytes was seen in patients with non-infectious systemic inflammatory response syndrome (SIRS) compared to control subjects (n = 14/group) [14].